| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7M | +20.8% | +99.9% |
| Cost of Revenue | $1.1M | -4.4% | +29.4% |
| Gross Profit | $2.7M | +35.1% | +155.9% |
| R&D Expense | $14.1M | +10.9% | +62.4% |
| SG&A Expense | $9.4M | +2.5% | +1.3% |
| Operating Income | -$27.7M | -4.7% | -34.4% |
| Net Income | -$140.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $836.2M | +2.1% | — |
| Accounts Receivable | $1.9M | +33.6% | +32.3% |
| Inventory | $2.8M | +15.6% | +48.8% |
| Current Assets | $848.1M | +2.4% | +2317.7% |
| Total Assets | $865.8M | +2.6% | +1647.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$53.6M | — | — |
| Capital Expenditures | $2.2M | — | — |
| Investing Cash Flow | -$1.6M | — | — |
| Financing Cash Flow | $712.0M | — | — |
| Free Cash Flow | -$55.8M | — | — |
| +16.3% |
| -516.4% |
| EPS (Basic) | -$0.41 | +25.5% | -272.7% |
| EPS (Diluted) | -$0.41 | +25.5% | -272.7% |
| $15.5M |
| -19.5% |
| -39.9% |
| Long-term Debt | $32.1M | -0.0% | +0.1% |
| Total Liabilities | $195.3M | +30.7% | +193.7% |
| Stockholders' Equity | $670.6M | -3.4% | +4064.3% |